Brought to you by:
First patient enrolled in HERCULES randomized trial comparing ESAR and EVAR
The first patient has been enrolled into the HERCULES trial, which compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) in the treatment of abdominal aortic aneurysms (AAAs) with wide proximal necks. HERCULES is an investigator-driven trial led by Michel Reijnen, MD,…
Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is taken by millions of people every day for type-2 diabetes, has an effect on the progression…
How the best leaders ensure psychological safety at work
My limited understanding of psychological safety is when people feel safe expressing differing opinions, and thoughts in the workplace. Amy Edmondson, a pioneer in this area, defines it as “the belief that the environment is safe for interpersonal risk-taking.”1 Although…
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was performed on Jan. 29, 2024, at the University of Texas Health (UTHealth) in Houston, Texas, by…
Mentor Match available for all SVS members
The SVS has expanded its Mentor Match program, which is now available to all SVS members in good standing. The program aims to connect vascular surgery professionals with experienced mentors who can help them achieve goals. Mentor Match began in…
SOOVC releases handbook for outpatient care
The SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) has released the anticipated Office-Based Lab (OBL) Handbook to guide practitioners and aid with safety and cost-effectiveness, as well as expand patients’ access to care. Anil Hingorani, MD, chair of…
Viabahn VBX stent graft receives FDA approval
Gore has announced recent Food and Drug Administration (FDA) approval of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft) for the treatment of complex iliac occlusive disease. “Our team is pleased to be the first commercial implanter of…
Endospan releases early TRIOMPHE IDE study results at Society of Thoracic Surgeons annual meeting
Endospan shared 30-day results from the first 22 patients enrolled in the TRIOMPHE investigational device exemption (IDE) study in a late-breaking presentation at the 60th annual meeting of the Society of Thoracic Surgeons (27–29 January, San Antonio, USA). TRIOMPHE is…
Southern Vascular elects first woman president-elect
The Southern Association for Vascular Surgery (SAVS) elected Margaret (Megan) Tracci, MD, to become its first ever woman president for the 2025–26 cycle. Tracci, a professor of surgery at the University of Virginia in Charlottesville, will serve as SAVS president-elect…
Gore receives FDA approval for breakthrough endovascular device in complex aortic aneurysms
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta. A press…